Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-03-30

Clinical Trial Update: Low Dose Versus Aggressive Inhibition of the Renin-Angiotensin-Aldosterone (RAS) to Treat Microalbuminuria [NA]

View source ↗

Summary

A completed clinical trial compared low-dose versus aggressive inhibition of the renin-angiotensin-aldosterone system (RAS) to treat microalbuminuria; results w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Charles Drew University of Medicine and Science | Conditions: Microalbuminuria | NA | Status: COMPLETED | Results posted: 2012-03-30